株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の粘弾性補充療法市場調査と予測

Global Viscosupplementation Market Research and Forecast, 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 770573
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.28円で換算しております。
Back to Top
世界の粘弾性補充療法市場調査と予測 Global Viscosupplementation Market Research and Forecast, 2018-2023
出版日: 2018年12月28日 ページ情報: 英文
概要

当レポートでは、世界の粘弾性補充療法市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 レポートのサマリー

第2章 市場概要と洞察

  • 市場の定義
  • バリューチェーン
  • アナリストの見解と現在の市場動向
  • 法規制

第3章 市場決定因子

  • 促進因子
  • 阻害因子
  • 機会

第4章 市場セグメンテーション

  • 用途別市場
    • 膝関節
    • 股関節
    • 足首関節
    • 肩関節
    • 脊椎
  • 製品別市場
    • 単回注射
    • 三回注射
    • 五回注射

第5章 競合環境

  • 主要企業分析
  • 主要戦略分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の諸国

第7章 企業プロファイル

  • Anika Therapeutics, Inc.
  • Depuy Synthes, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Ferring Pharmaceuticals B.V.
  • Fidia Farmaceutici S.p.A.
  • KalVista Pharmaceuticals, Inc.
  • LG Life Sciences, Ltd.
  • Lifecore Biomedical, LLC
  • Maxigen Biotech, Inc.
  • PendoPharm Inc.
  • Regen Lab SA
  • Sanofi-Aventis US LLC
  • Seikagaku Corporation
  • Shanghai Haohai Biological Technology Co., Ltd.
  • Smith & Nephew PLC.
  • Stellar Pharmaceuticals, Inc.
  • Stryker Corporation
  • Swiss Biomed Orthopaedics AG
  • Virchow Biotech Pvt. Ltd.
  • Zimmer Biomet Holdings, Inc
図表

List of Tables

  • TABLE # 1 GLOBAL VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL KNEE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 3 GLOBAL HIP MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 4 GLOBAL ANKLE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 5 GLOBAL SHOULDER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 6 GLOBAL SPINE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 7 GLOBAL VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 8 GLOBAL SINGLE-INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 9 GLOBAL THREE-INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 10 GLOBAL FIVE-INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 11 GLOBAL VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
  • TABLE # 12 NORTH AMERICA VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 13 NORTH AMERICA VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 14 NORTH AMERICA VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 15 EUROPE VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 16 EUROPE VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
  • TABLE # 17 EUROPE VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 18 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 19 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 20 ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
  • TABLE # 21 REST OF THE WORLD VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 22 REST OF THE WORLD VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE BY APPLICATION, 2017 VS 2023 (%)
  • FIGURE # 2 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE BY PRODUCT, 2017 VS 2023 (%)
  • FIGURE # 3 GLOBAL VISCOSUPPLEMENTATION MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
  • FIGURE # 4 US VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 5 CANADA VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 6 UK VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 FRANCE VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 8 GERMANY VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 ITALY VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 SPAIN VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 ROE VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 INDIA VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 CHINA VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 JAPAN VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 15 REST OF ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 REST OF THE WORLD VISCOSUPPLEMENTATION MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2018462

Viscosupplementation is a medical procedure used for the treatment of osteoarthritis symptoms. It is a non-invasive procedure under which lubricating fluid is injected into joints, which is also referred to as hyaluronic acid injections. It is intended to reduce joint pain and improves the condition of osteoarthritis joints, including knee, hip, ankle, shoulder, spine, wrist, and elbow. A significant rise in the prevalence of osteoarthritis has witnessed over the last decade. For instance, according to the Arthritis Foundation, an estimated 30.8 million adults in the US had osteoarthritis in 2015. It represents that osteoarthritis is the most common cause of disability among adults. These factors significantly increase the demand for the efficient procedure to treat osteoarthritis condition. This, in turn, is driving the adoption of viscosupplementation as it is one of the effective procedures to reduce joint pain and treatment of the condition.

Other factors that are encouraging the market growth include growing sports-related injuries, adoption of non-invasive procedures and increasing demand for knee osteoarthritis. Additionally, improving healthcare infrastructure and growing awareness about viscosupplementation is expected to offer a remarkable opportunity for the growth of the global viscosupplementation market. However, there are certain factors restricting the market growth comprising stringent regulations and adverse effects associated with viscosupplementation.

Furthermore, the global viscosupplementation market is segmented into application and products. Based on application, the market is classified into the knee, hip, ankle, shoulder, and spine. The demand for viscosupplementation in knee osteoarthritis is growing significantly due to its effectiveness to provide relief to the patients. Viscosupplementation for knee procedure is particularly useful for people who have not relieved from physical therapy, weight loss, and corticosteroid injections. Therefore, it is considered to be the most efficient method for the treatment of knee osteoarthritis which in turn is boosting the market. Based on the product, the market is classified into single-injection, three-injection, and five-injection.

On the basis of geography, the global viscosupplementation market is segmented into four major regions, including North America, Europe, Asia-Pacific, and Rest of the World. North America is gaining significant share in the global viscosupplementation market due to rising incidences of osteoarthritis in the US and Canada. Europe is also the major contributor to the market growth due to the high focus on providing patient-centered quality care in the region.

Some key companies of the global viscosupplementation market include Dr. Reddy's Laboratories Ltd., Anika Therapeutics, Inc., LG Life Sciences Ltd., Smith & Nephew Plc. and Zimmer Biomet Holdings, Inc. These companies adopt various strategies such as mergers & acquisition and product launches to be competitive in the market. in addition, the companies are receiving approval by the regulatory authorities for the launch of their product. For instance, In October 2017, Anika Therapeutics, Inc. has gained approval for MONOVISC in Australia. It is a single-injection viscosupplementation used for the treatment of osteoarthritis pain of all synovial joints which include knee and hip. This intends to further expand the availability of MONOVISC in the global markets.

Research Methodology

The market study of the global viscosupplementation market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, a country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

Financial reports of companies involved in the market

Authentic Public Databases such as Centers for Disease Control and Prevention, Arthritis Foundation and others.

Whitepapers, research-papers, and news blogs

Company websites and their product catalog

The report is intended for healthcare providers and government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

Global Viscosupplementation Market is segmented on the basis of regional outlook and following segments:

Global Viscosupplementation Market Research and Analysis, By Application

Global Viscosupplementation Market Research and Analysis, By Product

Global Viscosupplementation Market Research and Analysis, By Region

The Report Covers:

Comprehensive research methodology of global viscosupplementation market.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global viscosupplementation market.

Insights about market determinants which are stimulating the global viscosupplementation market

Table of Contents

CHAPTER 1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

CHAPTER 2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendation
    • 2.2.3. Conclusion
  • 2.3. Regulations

CHAPTER 3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. Increasing Prevalence of Osteoarthritis
    • 3.1.2. Growing Sports-Related Injuries
    • 3.1.3. Increasing Obesity and Geriatric Population
  • 3.2. Restraints
    • 3.2.1. Adverse Effects Associated with Viscosupplementation
    • 3.2.2. Stringent Regulations for Viscosupplementation
  • 3.3. Opportunities
    • 3.3.1. Adoption of Non-Invasive Procedures

CHAPTER 4. Market Segmentation

  • 4.1. Global Viscosupplementation Market by Application
    • 4.1.1. Knee
    • 4.1.2. Hip
    • 4.1.3. Ankle
    • 4.1.4. Shoulder
    • 4.1.5. Spine
  • 4.2. Global Viscosupplementation Market by Product
    • 4.2.1. Single-Injection
    • 4.2.2. Three-Injection
    • 4.2.3. Five-Injection

CHAPTER 5. Competitive Landscape

  • 5.1. Key Company Analysis
  • 5.2. Key Strategy Analysis

CHAPTER 6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. RoE
  • 6.3. Asia-Pacific
    • 6.3.1. India
    • 6.3.2. China
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

CHAPTER 7. Company Profiles

  • 7.1. Anika Therapeutics, Inc.
  • 7.2. Depuy Synthes, Inc.
  • 7.3. Dr. Reddy's Laboratories Ltd.
  • 7.4. Ferring Pharmaceuticals B.V.
  • 7.5. Fidia Farmaceutici S.p.A.
  • 7.6. KalVista Pharmaceuticals, Inc.
  • 7.7. LG Life Sciences, Ltd.
  • 7.8. Lifecore Biomedical, LLC
  • 7.9. Maxigen Biotech, Inc.
  • 7.10. PendoPharm Inc.
  • 7.11. Regen Lab SA
  • 7.12. Sanofi-Aventis US LLC
  • 7.13. Seikagaku Corporation
  • 7.14. Shanghai Haohai Biological Technology Co., Ltd.
  • 7.15. Smith & Nephew PLC.
  • 7.16. Stellar Pharmaceuticals, Inc.
  • 7.17. Stryker Corporation
  • 7.18. Swiss Biomed Orthopaedics AG
  • 7.19. Virchow Biotech Pvt. Ltd.
  • 7.20. Zimmer Biomet Holdings, Inc.
Back to Top